Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

7.67
Delayed Data
As of 4:00pm ET
 -0.05 / -0.65%
Today’s Change
6.44
Today|||52-Week Range
9.88
-10.50%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close7.72
Today’s open7.78
Day’s range7.66 - 7.78
Volume150,083
Average volume (3 months)278,740
Market cap$608.5M
Dividend yield--
Data as of 4:00pm ET, 03/30/2017

Growth & Valuation

Earnings growth (last year)-875.00%
Earnings growth (this year)+24.67%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+144.57%
P/E ratioNM
Price/Sales2.72
Price/Book3.70

Competitors

 Today’s
change
Today’s
% change
NVTAInvitae Corp+0.04+0.36%
NTRANatera Inc+0.12+1.36%
ENZEnzo Biochem Inc-0.12-1.44%
PTIProteostasis Therape...-0.21-1.89%
Data as of 4:02pm ET, 03/30/2017

Financials

Next reporting dateApril 26, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$244.1M
Annual profit (last year)-$5.7M
Net profit margin-2.34%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Vice President-
Operations
Mark Machulcz
Corporate headquarters
Fort Myers, Florida

Forecasts


Search for Jobs